Hospitals, clinics and CVS testing sites across the US have used the rapid tests from Abbott Laboratories [CNN]
Abbott Laboratories (ABT)
Last abbott laboratories earnings: 4/16 07:30 am
Check Earnings Report
US:NYSE Investor Relations:
abbott.com/investors.html
Company Research
Source: CNN
Clinical pathologists and lab scientists at the Cleveland Clinic said the Abbott system has produced higher false negatives than other devices they tested.They processed more than 200 samples of Covid-19 using five testing systems and found that ID NOW detected the virus in only 84.4% of the specimens, a spokesperson for the Ohio-based medical center told CNN.ID NOW and another test had higher false negative rates than the other devices assessed, the spokesperson said.NPR first reported about the assessmentThe Cleveland Clinic spokesperson told CNN that a dilution effect can occur whenever a sample swab is placed into viral transport media, but she added that in the assessment, "all tests were performed from the same viral transport media, so it was a true head-to-head comparison."The guidance from Abbott Laboratories comes more than two weeks after President Donald Trump said in a Rose Garden news conference that the company's rapid coronavirus test would be "a whole new ballgame" in
Show less
Read more
Impact Snapshot
Event Time:
ABT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ABT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ABT alerts
High impacting Abbott Laboratories news events
Weekly update
A roundup of the hottest topics
ABT
News
- Abbott Laboratories (NYSE: ABT) had its price target lowered by analysts at Barclays PLC from $141.00 to $140.00. They now have an "overweight" rating on the stock.MarketBeat
- Should You Pick Abbott Stock At $105 After An Upbeat Q1? [Forbes]Forbes
- Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario [Seeking Alpha]Seeking Alpha
- D-dimer Testing Market to hit USD 2 Bn by 2032, says Global Market Insights Inc. [Yahoo! Finance]Yahoo! Finance
- We Think Some Shareholders May Hesitate To Increase Abbott Laboratories' (NYSE:ABT) CEO Compensation [Yahoo! Finance]Yahoo! Finance
ABT
Earnings
- 4/17/24 - Beat
ABT
Sec Filings
- 4/17/24 - Form 8-K
- 4/2/24 - Form 4
- 4/2/24 - Form 4
- ABT's page on the SEC website